Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of Esophagus
Clinical trial NCT05424432 · UNKNOWN
Trial details
- NCT number
- NCT05424432
- Sponsor
- Jiangsu Cancer Institute & Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-29
- Primary completion
- 2023-12-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.